The present invention relates to at least one anti-IL-12 antibody, including
isolated nucleic acids that encode at least one anti-IL-12 antibody, IL-12, vectors,
host cells, transgenic animals or plants, and methods of making and using thereof,
including therapeutic compositions, methods and devices.